Skip to content

Contact +44 (0) 20 7060 7474 email us

Therapeutic

Irritable Bowel Syndrome Therapy Area Pipeline Report

 

Publication Date January 2010
Publisher Life Science Analytics
Product Type Report
Pages 177
ISBN Number not applicable
Product Code LSA07625

Price

£985.00
approximately: $1,491 | €1,099

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Life Science Analytics', Irritable Bowel Syndrome Therapy Area Pipeline Report contains detailed information on the irritable bowel syndrome drug pipeline. This report provides insight into the pipeline status of irritable bowel syndrome drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

  • Each Life Science Analytics' Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
  • In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
  • Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits:

  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
  • Keep track of your competitors and partners by better understanding their product pipeline.
  • Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
  • Maintain a critical competitive advantage.

Contents

  • Epidemiology Report
  • % of Products by Phase of Development
  • No. of Products by Phase of Development
  • Marketed Products vs. Pipeline Products
  • Company Overview - Pipeline Projects
  • Legend
    • Top 5 Companies in Early Stage Irritable Bowel Syndrome Products
    • Top 5 Companies in Late Stage Irritable Bowel Syndrome Products
    • Top 5 Companies in Marketed Irritable Bowel Syndrome Products
  • Patent Expirations
  • Upcoming Milestones
  • Product Sales
  • Full Pipeline View
    • Product Details : Unknown/Research
    • Product Details : Pre Clinical
    • Product Details : Phase I
    • Product Details : Phase II
    • Product Details : Phase III
    • Product Details : Pending Approval
    • Product Details : On the Market
  • News Updates
    • Deals & Alliances
    • Product Updates